Fluidigm Corporation develops and distributes systems based on the unique properties of Integrated Fluidic Circuits (IFCs) to precisely control fluids on a nano volume scale. The company's vision is to create and to lead a new industry in which IFCs bring unparalleled efficiencies to the life science and allied fields.

The BioMark system sets the new standard for high throughput real-time PCR assays and streamlines workflow for applications demanding sensitivity and dynamic range, at extremely high throughput.

The EP1 system sets the new standard for high throughput SNP genotyping and provides superior data quality with a fast and easy workflow and can also be used for end point digital PCR applications.